INMB INmune Bio Corporation Total Debt to Capital
INmune Bio, Inc. (INMB) relies on patents for selective TNF suppression to combat dementia, although business success is tied to trial results. These aspects complement the stock quotes shown on this chart, where the individual debt-to-equity ratio stands at 0.07. INmune Bio, Inc. (INMB) adheres to bioethics in cancer and Alzheimer's therapies, ensuring test transparency. Additionally, the biotech firm minimizes environmental impact through energy-efficient sample storage and chemical disposal.
Analytical breakdowns and data insights for company INmune Bio Corporation (INMB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:INMB - INmune Bio
Professional capital assesses the financial stability of INmune Bio, Inc. (INMB) through the balance of debt and equity, which is critical while awaiting clinical trial data and FDA verdicts. Analyzing the total debt-to-equity ratio allows for the determination of the degree of leverage: an increase in this indicator signals risks of excessive leverage, while its decline confirms business autonomy and the high survivability of the asset.
Main competitors
Debt to Equity argenx ARGX|Aggregate Debt to Equity BioNTech Inc.|Abivax SA (ABVX) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio ADMA Corp (ADMA)|Total Debt to Capital PTGX (Protagonist Therapeutics)|immunovant.com - Total Debt to Capital|Debt to Equity Kiniksa (KNSA)|GRFS: All Debt to Shareholders' Equity Ratio|ADPT (Adaptive Biotechnologies Corp) - Debt to Equity|Celldex Corp (CLDX) - Total Debt to Equity Ratio|AUPH (Aurinia Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital biocryst.com (BCRX)|Vera Therapeutics (VERA) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Dianthus Therapeutics Inc (DNTH)|Total Debt to Capital PHVS|AbCellera - Total Debt to Capital Coefficient|TRML: Debt to Equity|PGEN: Total Debt to Equity Ratio|PHAR (Pharming Group) - Debt to Equity|Total Debt to Equity Ratio Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Total Debt to Equity Ratio|Total Debt to Capital ZBIO|Debt to Equity Immunome, Inc. IMNM|Debt to Equity Ratio gossamerbio.com (GOSS)|KALV: Total Debt to Capital|Debt to Capital Septerna, Inc. SEPN|Total Debt to Capital PVLA (Pieris Pharmaceuticals Inc)|SVRA: Total Debt to Capital Coefficient|Debt to Equity Rigel Pharmaceuticals|ANAB (anaptysbio.com) - Debt to Equity Ratio|Debt to Equity ATXS|Total Debt to Equity Ratio enGene Holdings Inc (ENGN)|Total Debt to Equity Ratio RAPT|Total Debt to Capital JBIO (aerovatetx.com)|ACRS - Debt to Equity|Debt to Equity Ratio kyvernatx.com KYTX|TLSA (Tiziana Life Sciences Ltd) - Total Debt to Capital|Cabaletta Bio Inc. (CABA) - Debt to Capital|Total Debt to Equity Ratio Ventyx Bio VTYX|Theratechnologies, Inc (THTX) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital Avalo Therapeutics, Inc|Debt to Equity eledon.com|AGEN (Agenus Inc.) - Total Debt to Capital|Total Debt to Capital Coefficient CLYM (Climb Bio Inc.)|ZURA: Debt to Equity|ATYR - Debt to Capital|Total Debt to Equity Ratio Adagene Corp (ADAG)|IMA - All Debt to Shareholders' Equity Ratio|shattucklabs.com - Total Debt to Capital|EQ (Equillium) - Total Debt to Capital Coefficient|Debt to Equity Connect Biopharma Holdings (CNTB)|Debt to Equity Ratio Immunic Inc|Total Debt to Capital ATRA (Atara Biotherapeutics)|Total Debt to Equity Ratio inflarx.de IFRX|Total Debt to Equity Ratio XFOR|Total Debt to Capital Coefficient Adicet Bio Inc. ACET|Total Debt to Capital CELU (Celularity Corp)|BRNS: Total Debt to Capital Coefficient|Debt to Equity Kezar Life Sciences|SABS (sabbiotherapeutics.com) - Debt to Equity Ratio|Debt to Equity AKTX|Total Debt to Equity Ratio Enlivex Therapeutics, Ltd.|Total Debt to Capital Q32 Bio Inc. (QTTB)|Debt to Equity GOVX (GeoVax Corp)|Edesa Biotech, Inc. (EDSA) - Debt to Equity|Aggregate Debt to Equity ibioinc.com IBIO|Total Debt to Capital Carisma Tx (CARM)|XTLB - All Debt to Shareholders' Equity Ratio|BOLT: Total Debt to Capital|HCWB (HCW Biologics) - Total Debt to Capital|APVO - Debt to Equity|All Debt to Shareholders' Equity Ratio AIM|Debt to Equity ADTX (Aditxt)|Total Debt to Equity Ratio GRI Bio Inc (GRI)|Total Debt to Capital XRTX (XORTX)|HIND - Total Debt to Capital|Total Debt to Equity Ratio Revelation Biosciences (REVB)|INDP - All Debt to Shareholders' Equity Ratio|Scinai Immunotherapeutics Ltd. - Total Debt to Capital|CALI (CalciMedica) - Total Debt to Capital Coefficient|Debt to Equity AFMD|Total Debt to Equity Ratio ALLK|Debt to Equity HOOK (HOOKIPA Pharma Inc.)|Total Debt to Equity Ratio igmbio.com IGMS|Total Debt to Equity Ratio ITOS (iTeos Therapeutics, Inc.)|Ocean Biomedical Inc - Total Debt to Capital|TC BioPharm (Holdings) PLC (TCBP) - Debt to Equity|THRD - Debt to Equity Ratio